J. Guerin

发表

Antibodies to β2‐glycoprotein I—a specific marker for the antiphospholipid syndrome

C. Feighery, Robert B Sim, J. Guerin, 1997, Clinical and experimental immunology.

Detection of ‘antiphospholipid’ antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding β2‐glycoprotein I and prothrombin

T. Koike, J. Hanly, A. Sturgess, 2001, Clinical and experimental immunology.

The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test.

A. Tabarin, J. Corcuff, P. Roger, 1990, Acta endocrinologica.

Electrical properties of cultured human adrenocorticotropin-secreting adenoma cells: effects of high K+, corticotropin-releasing factor, and angiotensin II.

M. Rogawski, B. Dufy, P. Mollard, 1987, Endocrinology.

Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders

C. Feighery, B. White, O. Smith, 1998, British journal of haematology.

Usefulness of the corticotropin-releasing hormone test during bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's disease.

A. Tabarin, J. Caillé, P. Roger, 1991, The Journal of clinical endocrinology and metabolism.

Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease

J. Drouillard, A. Tabarin, P. Roger, 1998, Clinical endocrinology.

Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome

A. Tabarin, J. Corcuff, P. Roger, 1991, Clinical endocrinology.

Spontaneous and agonist-induced calcium oscillations in single human nonfunctioning adenoma cells

B. Dufy, P. Vacher, L. Bresson-Bepoldin, 1996, Endocrine.

Enzyme-linked immunosorbent assay for β2-glycoprotein I quantitation: the importance of variability in the plastic support

C. Feighery, H. O’Byrne, J. Guerin, 2003, British journal of biomedical science.

[Value of the CRF test in primary and secondary adrenal insufficiency].

A. Tabarin, P. Roger, J. Guerin, 1989, Annales d'endocrinologie.

An electrophysiological study of cultured human pituitary cells

J. Vincent, B. Dufy, H. Fleury, 1982, Molecular and Cellular Endocrinology.

Thyrotropin-releasing hormone and gonadotropin-releasing hormone-associated peptide modulation of [Ca2+]i in human lactotrophs

J. Rivel, P. Vacher, L. Dufy-barbe, 1993, Molecular and Cellular Endocrinology.

Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients.

C. Feighery, Eoin Casey, J. Guerin, 1999, Autoimmunity.

Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells

S. Boudina, D. Liguoro, P. Vacher, 2002, Glia.

Effect of naloxone and beta-casomorphin on the hypothalamic-pituitary-luteinizing hormone axis in vitro.

B. Saïag, V. Shacoori, B. Rault, 1992, Life sciences.

Heparin Inhibits the Binding of β2-glycoprotein I to Phospholipids and Promotes the Plasmin-mediated Inactivation of This Blood Protein

G. M. Iverson, S. Reddel, S. Krilis, 2002, The Journal of Biological Chemistry.

Heterogeneous Recognition of beta 2-glycoprotein I by Antibodies from Antiphospholipid Syndrome Patients

C. Feighery, J. Ferluga, J. Guerin, 2000, Thrombosis and Haemostasis.

The electrophysiological effects of thyrotropin-releasing hormone are similar in human TSH- and prolactin-secreting pituitary cells.

B. Dufy, P. Mollard, G. Manciet, 1988, The Journal of clinical endocrinology and metabolism.

Heparin Inhibits the Binding of β2-glycoprotein I to Phospholipids and Promotes the Plasmin-mediated Inactivation of This Blood Protein

S. Reddel, S. Krilis, M. Chapman, 2002, The Journal of Biological Chemistry.